ICB International, Inc

Innovative California Biosciences International, Inc.,('ICBI'), an immunology and biomedicine company, has developed a proprietary blood-brain barrier (BBB) permeable technology to address issues relating to the diseases of the central nervous system (CNS). This platform technology is now being leveraged to develop FDA (Food and Drug Administration) approved non-invasive diagnostics and therapeutics for neurodegenerative, cancer, and infectious diseases.

Applications of ICBI's platform technology